FLASH Radiotherapy for Skin Cancer
NCT: NCT05724875 · ACTIVE_NOT_RECRUITING
Brief Summary
This is a single center randomized selected Phase II study of FLASH radiotherapy (RT) versus standard of care (SOC) radiotherapy in patients with localized Cutaneous Squamous Cell Carcinoma (cSCC) or Basal Cell Carcinoma (BCC). In summary, the aims of the study are to describe and compare the toxicity and efficacy of high dose rate radiotherapy (FLASH therapy) to SOC conventional radiotherapy (according to the standard guidelines per lesion size) through a randomized Phase II selection study in patients presenting localized cSCC or BCC requiring a radiotherapy treatment.
Frequently Asked Questions
What is FLASH Radiotherapy for Skin Cancer?
FLASH Radiotherapy for Skin Cancer is a clinical trial registered under NCT05724875. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05724875?
The current status of NCT05724875 (FLASH Radiotherapy for Skin Cancer) is: ACTIVE_NOT_RECRUITING.
When did FLASH Radiotherapy for Skin Cancer start?
FLASH Radiotherapy for Skin Cancer started on 2023-06-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.